363 related articles for article (PubMed ID: 28840135)
1. Assessment of Mediastinal Tumors Using SUV
Morita T; Tatsumi M; Ishibashi M; Isohashi K; Kato H; Honda O; Shimosegawa E; Tomiyama N; Hatazawa J
Asia Ocean J Nucl Med Biol; 2017; 5(1):22-29. PubMed ID: 28840135
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma.
Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC
Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144
[TBL] [Abstract][Full Text] [Related]
3. Value of 18F-FDG PET/CT for Predicting the World Health Organization Malignant Grade of Thymic Epithelial Tumors: Focused in Volume-Dependent Parameters.
Park SY; Cho A; Bae MK; Lee CY; Kim DJ; Chung KY
Clin Nucl Med; 2016 Jan; 41(1):15-20. PubMed ID: 26545017
[TBL] [Abstract][Full Text] [Related]
4. Optimal FDG PET/CT volumetric parameters for risk stratification in patients with locally advanced non-small cell lung cancer: results from the ACRIN 6668/RTOG 0235 trial.
Salavati A; Duan F; Snyder BS; Wei B; Houshmand S; Khiewvan B; Opanowski A; Simone CB; Siegel BA; Machtay M; Alavi A
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1969-1983. PubMed ID: 28689281
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Value of Volume-Based Fluorine-18-Fluorodeoxyglucose PET/CT Parameters for Characterizing Thyroid Incidentaloma.
Shi H; Yuan Z; Yuan Z; Yang C; Zhang J; Shou Y; Zhang W; Ping Z; Gao X; Liu S
Korean J Radiol; 2018; 19(2):342-351. PubMed ID: 29520193
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of Combined Metabolic-Volumetric Indices of (18)F-FDG PET/CT for the Early Prediction of Neoadjuvant Chemotherapy Outcomes in Breast Cancer.
Im HJ; Kim YK; Kim YI; Lee JJ; Lee WW; Kim SE
Nucl Med Mol Imaging; 2013 Mar; 47(1):36-43. PubMed ID: 24895506
[TBL] [Abstract][Full Text] [Related]
7. Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors.
Zhu L; Li X; Wang J; Fu Q; Liu J; Ma W; Xu W; Chen W
Cancer Biol Med; 2020 May; 17(2):468-477. PubMed ID: 32587782
[No Abstract] [Full Text] [Related]
8. The clinical value of texture analysis of dual-time-point
Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T
Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of Preoperative
Ishibashi M; Tanabe Y; Yunaga H; Miyoshi H; Miwa K; Nakamura H; Fujii S; Ogawa T
Yonago Acta Med; 2019 Mar; 62(1):146-152. PubMed ID: 30962757
[TBL] [Abstract][Full Text] [Related]
10. Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters.
Lee H; Chung YS; Lee JH; Lee KY; Hwang KH
World J Clin Cases; 2022 Jan; 10(1):155-165. PubMed ID: 35071515
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of metabolic parameters at
Yajima T; Mogi A; Shimizu K; Kosaka T; Ohtaki Y; Obayashi K; Nakazawa S; Nakajima T; Tsushima Y; Shirabe K
Oncol Lett; 2020 Mar; 19(3):1865-1871. PubMed ID: 32194681
[TBL] [Abstract][Full Text] [Related]
12. The Evaluation of Preoperative
Vural Topuz Ö; Aksu A; Erinç SR; Tokgözoğlu N; Tamam MÖ
Mol Imaging Radionucl Ther; 2022 Feb; 31(1):16-22. PubMed ID: 35114747
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic value of pretreatment (18)F-FDG PET-CT for patients with advanced diffuse large B-cell lymphoma].
Ding CY; Guo Z; Sun J; Yang WP; Li TR
Zhonghua Zhong Liu Za Zhi; 2018 Jul; 40(7):528-533. PubMed ID: 30060362
[No Abstract] [Full Text] [Related]
14.
Satoh K; Sadowski SM; Dieckmann W; Quezado M; Nilubol N; Kebebew E; Patel D
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):714-721. PubMed ID: 27638678
[TBL] [Abstract][Full Text] [Related]
15. Volume-based parameters on FDG PET may predict the proliferative potential of soft-tissue sarcomas.
Kitao T; Shiga T; Hirata K; Sekizawa M; Takei T; Yamashiro K; Tamaki N
Ann Nucl Med; 2019 Jan; 33(1):22-31. PubMed ID: 30196378
[TBL] [Abstract][Full Text] [Related]
16. The role of FDG PET/CT in evaluation of mediastinal masses and neurogenic tumors of chest wall.
Tatci E; Ozmen O; Dadali Y; Biner IU; Gokcek A; Demirag F; Incekara F; Arslan N
Int J Clin Exp Med; 2015; 8(7):11146-52. PubMed ID: 26379916
[TBL] [Abstract][Full Text] [Related]
17. Total lesion glycolysis by 18F-FDG PET/CT is a reliable predictor of prognosis in soft-tissue sarcoma.
Choi ES; Ha SG; Kim HS; Ha JH; Paeng JC; Han I
Eur J Nucl Med Mol Imaging; 2013 Dec; 40(12):1836-42. PubMed ID: 23880967
[TBL] [Abstract][Full Text] [Related]
18. The value of different
Anwar H; Vogl TJ; Abougabal MA; Grünwald F; Kleine P; Elrefaie S; Nour-Eldin NA
Ann Nucl Med; 2018 Dec; 32(10):687-694. PubMed ID: 30219989
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ
Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043
[TBL] [Abstract][Full Text] [Related]
20. Fully Automatic Quantitative Measurement of 18F-FDG PET/CT in Thymic Epithelial Tumors Using a Convolutional Neural Network.
Han S; Oh JS; Kim YI; Seo SY; Lee GD; Park MJ; Choi S; Kim HR; Kim YH; Kim DK; Park SI; Ryu JS
Clin Nucl Med; 2022 Jul; 47(7):590-598. PubMed ID: 35675135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]